Clinical Trial Update: DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing DAPAgliflozin to a thiazide diuretic in patients with heart failure and diuretic resistance. Status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Heart Failure | Phase 3 | Status: UNKNOWN